NovaBay Pharmaceuticals Inc
NBY
Mkt cap
$51.92M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-06-30)
$2.21M
EPS (H1 2026)
$3.00
Gross Margin (qtr ended 2026-06-30)
N/A
Profit Margin (qtr ended 2026-06-30)
-1861.74%
Beta
0.16
Div yield
N/A
Sector
Healthcare
NovaBay Pharmaceuticals Inc (NBY) is a biotechnology company listed on US.
Latest reported NBY revenue for 2026-06-30 was $2.2M. Net income was -$41.1M. Revenue was down 10.4% from 2026-03-31 to 2026-06-30. NBY currently screens at market cap $51.9M.
Use this NBY research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full NBY income, balance, and cash tables.
NovaBay Pharmaceuticals Inc (NBY) is a biotechnology company in the Healthcare sector.
Latest cached NovaBay Pharmaceuticals Inc (NBY) revenue for Jun 30, 2026 was $2.2M. Net income was -$41.1M. Statements: https://lician.com/financials/nby
NovaBay Pharmaceuticals Inc (NBY) market capitalization is $51.9M on the latest cached snapshot.
The latest cached NBY filing is 8-K · Jan 16, 2026. Filings: https://lician.com/sec/nby